Methamphetamine Clinical Trials

Methamphetamine Clinical Trials

Each year, 24.7 million people use amphetamine (MA) worldwide, which represents more consumers than individuals who use heroin or cocaine. Despite these numbers, there are currently no FDA-approved medications to treat MA dependence. And while behavioral counseling options can help many, too often it is not enough. UCLA CBAM is one of the leading methamphetamine research groups in the nation and is working to translate the latest scientific discoveries into new and more effective treatments for methamphetamine addiction. Information concerning our current methamphetamine clinical trial is below:

Meth Facts and Resources

Methamphetamine is a highly addictive stimulant. It is known by many names including meth, ice, speed, crystal, crank, fire, glass, and tweek. Meth appears as white or yellow crystalline powder or as a large hard rock. It is odorless and has a bitter taste.

Effects of methamphetamine are severe and can include increased heart rate and blood pressure, seizures, stroke, psychosis and death. Short term effects of the drug include nausea, vomiting, convulsions, tremors, anxiety, and paranoia.

Withdrawal symptoms can include stomach cramps, intense hunger, headaches, shortness of breath, exhaustion and severe depression.

For more information, visit the National Institute on Drug Abuse.

GET HELP

Interested in participating in a research study or have questions about counseling, therapy or addiction treatment? Call us at (866) 449-8252 or email us at uclavsc@mednet.ucla.edu to get more information about research studies of medical treatment for meth addiction or referrals to other programs that may be appropriate for substance addiction.

 

Video: Targeting Brain Inflammation to Treat Methamphetamine Addiction

Watch CBAM’s Medical Director Dr. Keith Heinzerling explain how targeting brain inflammation can treat methamphetamine addiction.

About

CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.